You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com | |
Most viewed
- 1. Healthera secures £2m strategic investment to accelerate digital pharmacy platform growth and North American expansion
- 2. RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING'S SYNDROME
- 3. Transcriptome sequencing revealed that lymph node metastasis of papillary thyroid microcarcinoma is associated with high THBS4 expression and PDGFRA+ cancer-associated fibroblasts
- 4. SECuRE trial update: First patient treated in the Phase II Cohort Expansion
- 5. Temporal dynamics of lymphocytes in prostate cancer patients treated with proton therapy
- 6. Meta-analysis of medical cannabis outcomes and associations with cancer
- 7. Validation of machine learning-based models to predict and explain the risk of ovarian cancer: a multicentric study on BRCA-mutated patients undergoing risk-reducing salpingo-oophorectomy
- 8. Identifying antisense oligonucleotides for targeted inhibition of insulin receptor isoform A
- 9. Study shows how new antibody therapy works against ovarian cancer
- 10. Disrupting calcium homeostasis and glycometabolism in engineered lipid-based pharmaceuticals propel cancer immunogenic death
Last updated at 0:53 GMT
Hot News Makers
Health/Pharma Companies
- 270345.90
- 21133.11
- 11414.38
- 9457.08
- 7483.21
- 7418.56
- 7011.21
- 6939.73
- 5459.28
- 5211.12
Drugs, Treatments, Trials
- 19800.35
- 7582.59
- 7291.18
- 6713.55
- 6434.08
- 5707.00
- 4789.20
- 4047.46
- 3748.08
- 3609.89
Last updated at 0:10 GMT
